Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Endovascular Therapy for Aneurysm Bleeds

By HospiMedica staff writers
Posted on 23 Aug 2005
The results of a new study show that endovascular therapy can lead to significant recovery for patients with the most severe effects of aneurysm bleeds, called subarachnoid hemorrhage (SAH).

Cerebral aneurysms result from a weakened area in the blood vessel that causes a bulge in the vessel wall. More...
When the bulge ruptures, a bleed occurs, which can cause severe disability or death. An endovascular treatment uses catheters to place platinum coils in the aneurysm, thereby blocking blood flow to the aneurysm and reducing the risk of rupture. The treatment has been proven as a good alternative to the more invasive practice of surgical clipping treatment.

The study was designed to evaluate the outcomes of endovascular treatment on patients with aneurysm ruptures who are suffering from coma, stupor, paralysis, or are otherwise too sick to undergo surgery. The study involved 111 poor-grade patients, who were all treated within 10 days of aneurysm bleeding, with 73 patients treated within three days of hemorrhage. Under radiologic guidance, a catheter was inserted directly into the groin and routed through the blood vessels leading to the brain. The coils were then introduced through the catheter and inserted directly into the affected area. Patients were also treated with aggressive medical management to maximize blood flow to the brain, typically safe only after the aneurysm is secured by coiling.

The patients were evaluated both at discharge and at 32 months following the aneurysm bleed. The results showed that 39 patients (35%) demonstrated favorable outcomes. The results were reported at the annual meeting of the American Society of Interventional and Therapeutic Neuroradiology in Hawaii (USA).

"I can safely say that this study can offer treating physicians, patients, and patients' families hope in the treatment possibilities even when patients' conditions are grave,” said co-author Gary Duckwiler, M.D., of the University of California at Los Angeles (UCLA, USA).





Related Links:
U. of California, Los Angeles

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.